This study assesses the use of IL‐6 as an early biomarker in neonatal sepsis, particularly in preterm infants where CRP levels are negative but clinical suspicion of sepsis remains. A 3‐year retrospective analysis of preterm twins admitted to a neonatal intensive care unit (NICU) was conducted evaluating IL‐6 and CRP levels and correlating them with survival outcomes. IL‐6 was found to be an effective early marker in CRP‐negative cases, enabling timely antibiotic interventions and improving survival rates.
Umesh Joshi. IL‐6 as an Early Biomarker in Neonatal Sepsis: A 3‐Year Retrospective Analysis in Preterm Twins.
DOI: https://doi.org/10.36478/10.36478/makrjms.2024.11.215.218
URL: https://www.makhillpublications.co/view-article/1815-9346/10.36478/makrjms.2024.11.215.218